Reply to Chen : BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
作者信息
Provencher Steeve, Boucherat Olivier, Berger Rolf M F, Goumans Marie-José, Bonnet Sébastien
机构信息
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université LavalQuébec, Quebec, Canada.
University of GroningenGroningen, the Netherlandsand.
出版信息
Am J Respir Crit Care Med. 2020 May 15;201(10):1313-1314. doi: 10.1164/rccm.202001-0059LE.
Abstract
摘要
相似文献
1
Reply to Chen : BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?对陈的回复：BET信号传导：肺动脉高压的新型治疗靶点？
Am J Respir Crit Care Med. 2020 May 15;201(10):1313-1314. doi: 10.1164/rccm.202001-0059LE.
2
BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?溴结构域和额外末端结构域（BET）信号传导：肺动脉高压的新型治疗靶点？
Am J Respir Crit Care Med. 2020 May 15;201(10):1313. doi: 10.1164/rccm.201912-2525LE.
3
EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition.EpiHope用于治疗肺动脉高压：选择性与非选择性BET抑制作用
Am J Respir Crit Care Med. 2019 Nov 1;200(9):1188-1190. doi: 10.1164/rccm.201906-1235LE.
4
Protease-activated receptor 1 as potential therapeutic target in pulmonary arterial hypertension.
Cardiovasc Res. 2019 Jul 1;115(8):1260-1261. doi: 10.1093/cvr/cvz071.
5
Reply to Ning : More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension.致宁的回复：对RVX-208与肺动脉高压之间关联的更多见解
Am J Respir Crit Care Med. 2020 Feb 1;201(3):389-391. doi: 10.1164/rccm.201909-1800LE.
6
Reply to Weatherald : Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?对韦瑟罗尔德的回复：肺动脉高压中的肺血管阻力：关键因素？
Am J Respir Crit Care Med. 2021 Feb 15;203(4):525-526. doi: 10.1164/rccm.202010-3834LE.
7
Reply: COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match?回复：新型冠状病毒肺炎的经验与肺动脉高压：早期论点与新数据是否依然相符？
Ann Am Thorac Soc. 2021 Jun;18(6):1081-1082. doi: 10.1513/AnnalsATS.202102-117LE.
8
Risk scores as a surrogate in pulmonary arterial hypertension: a different lens - Authors' reply.肺动脉高压中作为替代指标的风险评分：另一种视角——作者回复
Lancet Respir Med. 2024 Mar;12(3):e11. doi: 10.1016/S2213-2600(24)00002-X.
9
Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?多组学：通往理解肺动脉高压之路的下一步？
Thorax. 2019 Apr;74(4):317-318. doi: 10.1136/thoraxjnl-2018-212840. Epub 2019 Jan 24.
10
Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.剖析肺动脉高压中的大熔炉现象
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1329-1331. doi: 10.1164/rccm.202001-0156ED.
本文引用的文献
1
Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.多中心临床前验证 BET 抑制剂治疗肺动脉高压。
Am J Respir Crit Care Med. 2019 Oct 1;200(7):910-920. doi: 10.1164/rccm.201812-2275OC.
2
Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.研究环境下心功能右心室评估：知识空白与前进道路。美国胸科学会官方研究声明。
Am J Respir Crit Care Med. 2018 Aug 15;198(4):e15-e43. doi: 10.1164/rccm.201806-1160ST.
3
Standards and Methodological Rigor in Pulmonary Arterial Hypertension Preclinical and Translational Research.肺动脉高压临床前和转化研究中的标准和方法学严谨性。
Circ Res. 2018 Mar 30;122(7):1021-1032. doi: 10.1161/CIRCRESAHA.117.312579.
4
Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension.炎症和表观遗传阅读器在肺动脉高压患者冠状动脉重塑中的意义
Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1513-1523. doi: 10.1161/ATVBAHA.117.309156. Epub 2017 May 4.
5
Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension.溴结构域蛋白 4：肺动脉高压的表观遗传起源。
Circ Res. 2015 Aug 28;117(6):525-35. doi: 10.1161/CIRCRESAHA.115.307004. Epub 2015 Jul 29.
6
PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension.专利附加：一项关于 riociguat 加 sildenafil 治疗肺动脉高压的双盲、随机和扩展研究。
Eur Respir J. 2015 May;45(5):1314-22. doi: 10.1183/09031936.00105914. Epub 2015 Feb 5.
7
Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.右心对肺动脉高压的适应：生理学和病理生物学。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D22-33. doi: 10.1016/j.jacc.2013.10.027.
Zotero 插件